We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$69.1B
AUM Growth
+$6.99B
Cap. Flow
+$1.68B
Cap. Flow %
2.44%
Top 10 Hldgs %
21.7%
Holding
3,863
New
279
Increased
1,682
Reduced
1,438
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Financials 12.81%
3 Healthcare 11.02%
4 Consumer Discretionary 10.22%
5 Real Estate 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LESL icon
3526
Leslie's
LESL
$10.3M
$196 ﹤0.01%
3
-447
-99% -$27.6K
SST icon
3527
System1
SST
$17.7M
$196 ﹤0.01%
+18
New +$231
CXM icon
3528
Sprinklr
CXM
$1.61B
$193 ﹤0.01%
25
-123
-83% -$1.08K
EYPT icon
3529
EyePoint Inc
EYPT
$1.11B
$192 ﹤0.01%
24
-1,043
-98% -$9.16K
HUMA icon
3530
Humacyte
HUMA
$201M
$190 ﹤0.01%
35
-343
-91% -$2.26K
SOPH icon
3531
SOPHiA GENETICS
SOPH
$643M
$190 ﹤0.01%
52
TYRA icon
3532
Tyra Biosciences
TYRA
$1.58B
$188 ﹤0.01%
8
BY icon
3533
Byline Bancorp
BY
$1.75B
$187 ﹤0.01%
7
-12,100
-100% -$320K
PBFS icon
3534
Pioneer Bancorp
PBFS
$429M
$186 ﹤0.01%
+17
New +$185
TE
3535
T1 Energy
TE
$1.52B
$186 ﹤0.01%
+192
New +$262
GCBC icon
3536
Greene County Bancorp
GCBC
$582M
$185 ﹤0.01%
6
CLSD
3537
DELISTED
Clearside Biomedical
CLSD
$184 ﹤0.01%
10
-6
-38% -$102
HOWL icon
3538
Werewolf Therapeutics
HOWL
$19.4M
$182 ﹤0.01%
+86
New +$196
GUTS icon
3539
Fractyl Health
GUTS
$105M
$180 ﹤0.01%
+71
New +$232
ALXO icon
3540
ALX Oncology
ALXO
$288M
$178 ﹤0.01%
98
-2,233
-96% -$8.3K
AMPS
3541
DELISTED
Altus Power
AMPS
$175 ﹤0.01%
55
-7,901
-99% -$28.2K
ULBI icon
3542
Ultralife
ULBI
$117M
$172 ﹤0.01%
+19
New +$196
OPAD icon
3543
Offerpad Solutions
OPAD
$22.7M
$171 ﹤0.01%
+4
New +$161
BOLD
3544
Boundless Bio
BOLD
$65.5M
$170 ﹤0.01%
+49
New +$178
BLUE
3545
DELISTED
bluebird bio
BLUE
$169 ﹤0.01%
16
-665
-98% -$11.1K
FULC icon
3546
Fulcrum Therapeutics
FULC
$288M
$168 ﹤0.01%
+47
New +$349
KIDS icon
3547
OrthoPediatrics
KIDS
$609M
$163 ﹤0.01%
+6
New +$182
LFMD icon
3548
LifeMD
LFMD
$174M
$157 ﹤0.01%
30
-222,878
-100% -$1.29M
PRLD icon
3549
Prelude Therapeutics
PRLD
$394M
$157 ﹤0.01%
76
-1,405
-95% -$6.51K
OPRX icon
3550
OptimizeRx
OPRX
$128M
$154 ﹤0.01%
20
-11
-35% -$98

Similar funds

Russell Investments Group's Q3 2024 Portfolio in Review

As of Q3 2024, Russell Investments Group held 3,863 positions worth $69.1B, up 11% from $62.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Russell Investments Group's Q3 2024 filing shows 279 new, 1,682 increased, 1,438 reduced and 180 closed positions. Its largest new stake was Hewlett Packard Enterprise 7.625% Series C Preferred Stock: 1,239,800 shares worth $1.5M. The largest sale was Bank of America Series L, an estimated $861M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Russell Investments Group's largest Q3 2024 buy was Hewlett Packard Enterprise 7.625% Series C Preferred Stock: 1,239,800 shares worth $1.5M.
  • Russell Investments Group added most to Apple in Q3 2024, an estimated $212M increase.
  • Russell Investments Group's biggest Q3 2024 reduction was Bank of America Series L, cutting an estimated $861M.
  • Russell Investments Group fully exited WestRock Company in Q3 2024, selling an estimated $8.96M.
  • Russell Investments Group's ten largest holdings make up 22% of its $69.1B portfolio in Q3 2024.
  • Russell Investments Group opened 279 new positions and closed 180 in Q3 2024.
  • Russell Investments Group's portfolio value rose 11% quarter-over-quarter to $69.1B.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.